CL2012002451A1 - Procedimientos para preparacion de 2-(ciclohexilmetil)-n-{2-[(2s)-1-metilpirrolidin-2-il]etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida; uno de sus compuestos intermediarios; y la preparacion del mismo. - Google Patents
Procedimientos para preparacion de 2-(ciclohexilmetil)-n-{2-[(2s)-1-metilpirrolidin-2-il]etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida; uno de sus compuestos intermediarios; y la preparacion del mismo.Info
- Publication number
- CL2012002451A1 CL2012002451A1 CL2012002451A CL2012002451A CL2012002451A1 CL 2012002451 A1 CL2012002451 A1 CL 2012002451A1 CL 2012002451 A CL2012002451 A CL 2012002451A CL 2012002451 A CL2012002451 A CL 2012002451A CL 2012002451 A1 CL2012002451 A1 CL 2012002451A1
- Authority
- CL
- Chile
- Prior art keywords
- preparation
- tetrahydroisoquinolin
- methylpyrrolidin
- cyclohexylmethyl
- sulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Procedimiento para preparar 2-(ciclohexilmetil)-N-{2-[(2S)-1-metilpirrolidin-2-il]etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida y sales de la misma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31106910P | 2010-03-05 | 2010-03-05 | |
FR1059750 | 2010-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2012002451A1 true CL2012002451A1 (es) | 2012-11-30 |
Family
ID=44012569
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012002452A CL2012002452A1 (es) | 2010-03-05 | 2012-09-04 | Procedimientos para la preparacion de 2-(ciclohexilmetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida; uno de sus compuestos interemdiarios; y la preparacion del mismo. |
CL2012002451A CL2012002451A1 (es) | 2010-03-05 | 2012-09-04 | Procedimientos para preparacion de 2-(ciclohexilmetil)-n-{2-[(2s)-1-metilpirrolidin-2-il]etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida; uno de sus compuestos intermediarios; y la preparacion del mismo. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012002452A CL2012002452A1 (es) | 2010-03-05 | 2012-09-04 | Procedimientos para la preparacion de 2-(ciclohexilmetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida; uno de sus compuestos interemdiarios; y la preparacion del mismo. |
Country Status (27)
Country | Link |
---|---|
US (2) | US8748615B2 (es) |
EP (2) | EP2542530A2 (es) |
JP (2) | JP2013521308A (es) |
KR (2) | KR20130047685A (es) |
CN (2) | CN103221394A (es) |
AR (2) | AR080374A1 (es) |
AU (2) | AU2011222588B2 (es) |
BR (2) | BR112012022356A2 (es) |
CA (2) | CA2789669A1 (es) |
CL (2) | CL2012002452A1 (es) |
CO (2) | CO6630099A2 (es) |
CR (1) | CR20120467A (es) |
DO (1) | DOP2012000228A (es) |
EC (1) | ECSP12012207A (es) |
GT (1) | GT201200228A (es) |
IL (2) | IL221339A0 (es) |
MA (2) | MA34144B1 (es) |
MX (2) | MX2012009413A (es) |
NZ (2) | NZ602009A (es) |
PE (1) | PE20130007A1 (es) |
RU (2) | RU2012142310A (es) |
SG (2) | SG182576A1 (es) |
TN (1) | TN2012000361A1 (es) |
TW (2) | TW201144285A (es) |
UY (2) | UY33262A (es) |
WO (2) | WO2011109680A2 (es) |
ZA (1) | ZA201205311B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR080374A1 (es) | 2010-03-05 | 2012-04-04 | Sanofi Aventis | Procedimiento para la preparcion de 2-(ciclohexilmetil)-n-(2-((2s)-1-metilpirrolidin-2-il) etil)- 1,2,3,4-tetrahidroisoquinolin-7- sulfonamida |
CN102816101A (zh) * | 2012-08-21 | 2012-12-12 | 江苏恒祥化工有限责任公司 | 一种(s)-n-甲基-2氯乙基吡咯烷的合成方法 |
KR20160048930A (ko) * | 2013-09-09 | 2016-05-04 | 사노피 | 알츠하이머 질환의 치료에 사용하기 위해 콜린에스테라제 저해제와 조합된 h3 수용체 길항제 |
JP2020536100A (ja) * | 2017-10-04 | 2020-12-10 | セルジーン コーポレイション | シス−4−[2−{[(3s,4r)−3−フルオロキサン−4−イル]アミノ}−8−(2,4,6−トリクロロアニリノ)−9h−プリン−9−イル]−1−メチルシクロヘキサン−1−カルボキサミドの製造プロセス |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4228170A (en) | 1979-08-30 | 1980-10-14 | Smithkline Corporation | 7- and/or 8-Sulfur substituted 1,2,3,4-tetrahydroisoquinoline compounds |
US4315935A (en) * | 1980-04-14 | 1982-02-16 | Smithkline Corporation | N,N'-Bis[substituted-1,2,3,4-tetrahydroisoquinolinolyl]disulfonylimides and antiallergic compositions and method of use |
GB8717374D0 (en) | 1987-07-22 | 1987-08-26 | Smith Kline French Lab | Pharmaceutically active compounds |
US4857301A (en) | 1987-09-25 | 1989-08-15 | Schering Corporation | Sulfonamide compounds, compositions and method of use |
AU7102394A (en) | 1993-06-09 | 1995-01-03 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
GB9322976D0 (en) | 1993-11-08 | 1994-01-05 | Pfizer Ltd | Therapeutic agents |
GB9709303D0 (en) * | 1997-05-09 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
HUP0101137A3 (en) | 1998-04-10 | 2003-03-28 | Japan Tobacco Inc | Anticoagulant amidines and their pharmaceutical use |
GB9816984D0 (en) | 1998-08-05 | 1998-09-30 | Smithkline Beecham Plc | Novel compounds |
EP1122252A4 (en) | 1998-10-16 | 2002-06-26 | Takeda Chemical Industries Ltd | CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM |
AU768720B2 (en) | 1999-04-01 | 2004-01-08 | Pfizer Products Inc. | Aminopyrimidines as sorbitol dehydrogenase inhibitors |
GB9912410D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
AR025884A1 (es) | 1999-10-01 | 2002-12-18 | Takeda Pharmaceutical | Compuestos de amina ciclica, su produccion y su uso |
EP1236719A4 (en) | 1999-12-03 | 2003-06-25 | Kyoto Pharma Ind | NOVEL HETEROCYCLIC COMPOUNDS AND SALTS THEREOF, USE OF THESE COMPOUNDS IN MEDICINE |
FR2804429B1 (fr) | 2000-01-31 | 2003-05-09 | Adir | Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2807434B1 (fr) | 2000-04-05 | 2002-10-18 | Hoechst Marion Roussel Inc | Nouveaux derives de la 1,2,3,4-tetrahydroisoquinoleine, leur procede de preparation et leur application comme fongicides |
BR0114552A (pt) | 2000-10-20 | 2003-07-01 | Biovitrum Ab | N1- (benzenosulfonil) indóis 2-,3-,4-, 5- substituìdos e seu uso em terapia |
ATE315023T1 (de) * | 2000-10-30 | 2006-02-15 | Warner Lambert Co | Aminoalkylpyrrolidine als serotoninrezeptorliganden sowie diese enthaltende zusammensetzungen, pharmazeutische verwendungen und methoden zu deren synthese |
WO2002076925A2 (en) | 2001-03-23 | 2002-10-03 | Eli Lilly And Company | Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
WO2002102770A1 (fr) * | 2001-06-18 | 2002-12-27 | Maruha Corporation | Nouveau compose aliphatique, technique de synthese et technique d'utilisation |
CA2456096A1 (en) | 2001-08-01 | 2003-02-13 | Mochida Pharmaceutical Co., Ltd. | Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same |
US6677349B1 (en) | 2001-12-21 | 2004-01-13 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
JP2005513154A (ja) | 2001-12-26 | 2005-05-12 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 尿素誘導体 |
US6867224B2 (en) | 2002-03-07 | 2005-03-15 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods of preparation |
CN100384856C (zh) | 2003-04-17 | 2008-04-30 | 麦克公司 | 趋化因子受体活性调节剂杂环基环戊基四氢异喹啉和杂环基环戊基四氢吡啶并吡啶 |
FR2857695B1 (fr) | 2003-07-15 | 2007-04-20 | Saint Gobain Ct Recherches | Bloc pour la filtration de particules contenues dans les gaz d'echappement d'un moteur a combustion interne |
WO2005067502A2 (en) | 2004-01-02 | 2005-07-28 | Merck & Co., Inc. | Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
CA2553242A1 (en) | 2004-01-20 | 2005-08-04 | Merck & Co., Inc. | 2,6-disubstituted piperidines as modulators of chemokine receptor activity |
AU2005251678A1 (en) | 2004-04-26 | 2005-12-22 | Merck Sharp & Dohme Corp. | Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
JP2007534758A (ja) | 2004-04-26 | 2007-11-29 | メルク エンド カムパニー インコーポレーテッド | ケモカイン受容体活性調節物質であるテトラヒドロピラニルシクロペンチル1−置換及び1,1−二置換テトラヒドロイソキノリン |
BRPI0510665A (pt) | 2004-05-11 | 2007-12-04 | Incyte Corp | 3-(4-heteroarilcicloexilamino) ciclopentano-carboxiamidas como moduladores de receptores de quimiocinas |
FR2870846B1 (fr) | 2004-05-25 | 2006-08-04 | Sanofi Synthelabo | Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique |
US7470722B2 (en) | 2004-06-10 | 2008-12-30 | Kalypsys, Inc. | Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
ES2257168B1 (es) | 2004-08-18 | 2007-06-01 | Laboratorios Del Dr Esteve, S.A. | Ligandos del receptor 5-ht7. |
EP1630158A1 (en) | 2004-08-18 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | 5-HT7 receptor antagonists |
US7838675B2 (en) | 2004-08-28 | 2010-11-23 | Astrazeneca Ab | Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
SE0403086D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
ATE430747T1 (de) | 2004-12-21 | 2009-05-15 | Smithkline Beecham Corp | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren |
JP2008525419A (ja) | 2004-12-22 | 2008-07-17 | ファイザー・リミテッド | Hiv−1逆転写酵素の非ヌクレオシド阻害剤 |
JP4829900B2 (ja) | 2005-01-26 | 2011-12-07 | エフ.ホフマン−ラ ロシュ アーゲー | フェニルメタノン誘導体及びグリシントランスポーター1阻害剤としてのこれらの使用 |
DE102005015040A1 (de) | 2005-03-31 | 2006-10-05 | Sanofi-Aventis Deutschland Gmbh | Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
AR053845A1 (es) | 2005-04-15 | 2007-05-23 | Tibotec Pharm Ltd | 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450 |
ZA200709961B (en) | 2005-05-10 | 2009-07-29 | Vertex Pharma | Bicyclic derivatives as modulators of ion channels |
EP1911747A1 (en) | 2006-10-11 | 2008-04-16 | Laboratorios del Dr. Esteve S.A. | Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators |
WO2008136378A1 (ja) | 2007-04-27 | 2008-11-13 | Toyama Chemical Co., Ltd. | 新規なスルホンアミド誘導体またはその塩 |
US20110071197A1 (en) | 2008-04-16 | 2011-03-24 | Peter Nilsson | Bis-aryl compounds for use as medicaments |
WO2010127272A2 (en) | 2009-04-30 | 2010-11-04 | Concert Pharmaceuticals, Inc. | Hydroxyethylamino sulfonamide derivatives |
NZ597219A (en) | 2009-06-26 | 2013-05-31 | Sanofi Sa | Novel fumarate salts of a histamine h3 receptor antagonist |
AR080374A1 (es) | 2010-03-05 | 2012-04-04 | Sanofi Aventis | Procedimiento para la preparcion de 2-(ciclohexilmetil)-n-(2-((2s)-1-metilpirrolidin-2-il) etil)- 1,2,3,4-tetrahidroisoquinolin-7- sulfonamida |
-
2011
- 2011-03-03 AR ARP110100672A patent/AR080374A1/es unknown
- 2011-03-03 AR ARP110100673A patent/AR080375A1/es unknown
- 2011-03-04 CA CA2789669A patent/CA2789669A1/en not_active Abandoned
- 2011-03-04 NZ NZ602009A patent/NZ602009A/en not_active IP Right Cessation
- 2011-03-04 JP JP2012556252A patent/JP2013521308A/ja not_active Ceased
- 2011-03-04 UY UY0001033262A patent/UY33262A/es not_active Application Discontinuation
- 2011-03-04 CN CN2011800123082A patent/CN103221394A/zh active Pending
- 2011-03-04 WO PCT/US2011/027131 patent/WO2011109680A2/en active Application Filing
- 2011-03-04 BR BR112012022356A patent/BR112012022356A2/pt not_active IP Right Cessation
- 2011-03-04 UY UY0001033263A patent/UY33263A/es not_active Application Discontinuation
- 2011-03-04 SG SG2012052809A patent/SG182576A1/en unknown
- 2011-03-04 KR KR1020127025953A patent/KR20130047685A/ko not_active Application Discontinuation
- 2011-03-04 MX MX2012009413A patent/MX2012009413A/es active IP Right Grant
- 2011-03-04 CA CA2787427A patent/CA2787427C/en not_active Expired - Fee Related
- 2011-03-04 EP EP11708373A patent/EP2542530A2/en not_active Withdrawn
- 2011-03-04 NZ NZ601498A patent/NZ601498A/en not_active IP Right Cessation
- 2011-03-04 MA MA35288A patent/MA34144B1/fr unknown
- 2011-03-04 BR BR112012022234A patent/BR112012022234A2/pt not_active Application Discontinuation
- 2011-03-04 MX MX2012008422A patent/MX2012008422A/es active IP Right Grant
- 2011-03-04 WO PCT/US2011/027118 patent/WO2011109675A2/en active Application Filing
- 2011-03-04 TW TW100107250A patent/TW201144285A/zh unknown
- 2011-03-04 EP EP11708374.1A patent/EP2556064B1/en active Active
- 2011-03-04 PE PE2012001391A patent/PE20130007A1/es not_active Application Discontinuation
- 2011-03-04 RU RU2012142310/04A patent/RU2012142310A/ru not_active Application Discontinuation
- 2011-03-04 CN CN201180012335XA patent/CN103068815A/zh active Pending
- 2011-03-04 AU AU2011222588A patent/AU2011222588B2/en not_active Ceased
- 2011-03-04 JP JP2012556254A patent/JP5927126B2/ja not_active Expired - Fee Related
- 2011-03-04 AU AU2011223560A patent/AU2011223560A1/en not_active Abandoned
- 2011-03-04 TW TW100107248A patent/TW201144284A/zh unknown
- 2011-03-04 KR KR1020127020498A patent/KR101783679B1/ko active IP Right Grant
- 2011-03-04 RU RU2012142338/04A patent/RU2012142338A/ru not_active Application Discontinuation
- 2011-03-04 MA MA35286A patent/MA34142B1/fr unknown
- 2011-03-04 SG SG2012059242A patent/SG183256A1/en unknown
-
2012
- 2012-07-17 TN TNP2012000361A patent/TN2012000361A1/en unknown
- 2012-07-17 ZA ZA2012/05311A patent/ZA201205311B/en unknown
- 2012-07-19 US US13/553,455 patent/US8748615B2/en not_active Expired - Fee Related
- 2012-07-20 GT GT201200228A patent/GT201200228A/es unknown
- 2012-08-07 IL IL221339A patent/IL221339A0/en unknown
- 2012-08-07 IL IL221341A patent/IL221341A/en not_active IP Right Cessation
- 2012-08-21 DO DO2012000228A patent/DOP2012000228A/es unknown
- 2012-08-31 US US13/600,975 patent/US8779145B2/en not_active Expired - Fee Related
- 2012-09-04 CL CL2012002452A patent/CL2012002452A1/es unknown
- 2012-09-04 CL CL2012002451A patent/CL2012002451A1/es unknown
- 2012-09-13 CR CR20120467A patent/CR20120467A/es unknown
- 2012-10-02 EC ECSP12012207 patent/ECSP12012207A/es unknown
- 2012-10-04 CO CO12174787A patent/CO6630099A2/es not_active Application Discontinuation
- 2012-10-04 CO CO12174778A patent/CO6630129A2/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR117799A2 (es) | Sal(es) de dimetil-amida del ácido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxílico y procesos para su elaboración | |
UA113643C2 (xx) | N-цикліламіди як нематоциди | |
AR089818A1 (es) | Inhibidor de la quinasa que regula la señal de la apoptosis | |
EA201101148A1 (ru) | Новые гербициды | |
EA201101060A1 (ru) | Новые гербициды | |
EA201101146A1 (ru) | Новые гербициды | |
AR094935A1 (es) | Tosilato de n-hidroxi-4-{2-[3-(n,n-dimetilaminometil)benzofuran-2-ilcarbonil-amino]etoxi}benzamida (abexinostat) | |
AR095727A1 (es) | Preparación de intermediarios de pirimidina | |
WO2013150545A3 (en) | Process for preparation of benzimidazole derivatives and salts thereof | |
NI201200195A (es) | Procedimiento de preparación de la sal de l - arginina de perindoprilo | |
CL2016001172A1 (es) | Nuevos inhibidores de dgat2. | |
CL2012002451A1 (es) | Procedimientos para preparacion de 2-(ciclohexilmetil)-n-{2-[(2s)-1-metilpirrolidin-2-il]etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida; uno de sus compuestos intermediarios; y la preparacion del mismo. | |
EA201491227A1 (ru) | Новые производные морфолинила, подходящие для применения в качестве ингибиторов mogat-2 | |
DOP2011000398A (es) | Nuevas sales de fumarato de un antagonista del receptor de histamina h3 | |
BR112016021910A2 (pt) | Processo de preparação de 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h-imidazo[4,5-b]piridin-2-il)piridin-2-amina | |
CR20120169A (es) | Procesos para la preparación de 2-(1-feniletil)-isoindolin-1-ona | |
CL2008002892A1 (es) | Procedimiento de preparacion de sales quirales de esteres de (1r,5s)-anhidroecgonina sustituida. | |
NI201200127A (es) | Procedimiento para la preparación de 2 - ( ciclohexilmetil ) - n - { 2 - [ (2s) - 1 - metilpirrolidin - 2 - il ] etil } - 1, 2, 3, 4 - tetrahidroisoquinolin - 7 - sulfonamida. | |
RU2013110799A (ru) | Средство для профилактики и лечения диабета | |
RU2013134779A (ru) | 2-(5-этил-1,3,4-тиадиазолил)амид 2-(4-бромфенил)-4-оксо-4-фенил-2-бутеновой кислоты, обладающий анальгетической активностью | |
HN2012001859A (es) | Procedimiento para la preparacion de 2-(ciclohexilmetil)-n-{2[(2s)-1-metilpirrolidin-2-il]etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida | |
NI201100210A (es) | Nuevas sales de fumarato de un antagonista del receptor de histamina h3. | |
ECSP11011547A (es) | Nuevas sales de fumarato de un antagonista del receptor de histamina h3 | |
PL399182A1 (pl) | Sposób wytwarzania nilotinibu | |
UA106380C2 (ru) | Фумаратные соли антагониста гистаминового рецептора н3 |